rs2069453
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004935.4(CDK5):c.313-326C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00117 in 506,930 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0028 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00045 ( 1 hom. )
Consequence
CDK5
NM_004935.4 intron
NM_004935.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.74
Publications
2 publications found
Genes affected
CDK5 (HGNC:1774): (cyclin dependent kinase 5) This gene encodes a proline-directed serine/threonine kinase that is a member of the cyclin-dependent kinase family of proteins. Unlike other members of the family, the protein encoded by this gene does not directly control cell cycle regulation. Instead the protein, which is predominantly expressed at high levels in mammalian postmitotic central nervous system neurons, functions in diverse processes such as synaptic plasticity and neuronal migration through phosphorylation of proteins required for cytoskeletal organization, endocytosis and exocytosis, and apoptosis. In humans, an allelic variant of the gene that results in undetectable levels of the protein has been associated with lethal autosomal recessive lissencephaly-7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2015]
CDK5 Gene-Disease associations (from GenCC):
- lissencephaly 7 with cerebellar hypoplasiaInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDK5 | NM_004935.4 | c.313-326C>T | intron_variant | Intron 5 of 11 | ENST00000485972.6 | NP_004926.1 | ||
| CDK5 | NM_001164410.3 | c.312+406C>T | intron_variant | Intron 5 of 10 | NP_001157882.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CDK5 | ENST00000485972.6 | c.313-326C>T | intron_variant | Intron 5 of 11 | 1 | NM_004935.4 | ENSP00000419782.1 | |||
| CDK5 | ENST00000297518.4 | c.312+406C>T | intron_variant | Intron 5 of 10 | 1 | ENSP00000297518.4 | ||||
| CDK5 | ENST00000476691.1 | n.187C>T | non_coding_transcript_exon_variant | Exon 1 of 2 | 4 | |||||
| CDK5 | ENST00000487703.5 | n.677-326C>T | intron_variant | Intron 5 of 7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00285 AC: 434AN: 152124Hom.: 2 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
434
AN:
152124
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000451 AC: 160AN: 354688Hom.: 1 Cov.: 0 AF XY: 0.000385 AC XY: 71AN XY: 184494 show subpopulations
GnomAD4 exome
AF:
AC:
160
AN:
354688
Hom.:
Cov.:
0
AF XY:
AC XY:
71
AN XY:
184494
show subpopulations
African (AFR)
AF:
AC:
116
AN:
11042
American (AMR)
AF:
AC:
9
AN:
13934
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
11516
East Asian (EAS)
AF:
AC:
2
AN:
25918
South Asian (SAS)
AF:
AC:
2
AN:
31804
European-Finnish (FIN)
AF:
AC:
0
AN:
22928
Middle Eastern (MID)
AF:
AC:
1
AN:
1616
European-Non Finnish (NFE)
AF:
AC:
19
AN:
214598
Other (OTH)
AF:
AC:
11
AN:
21332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00284 AC: 433AN: 152242Hom.: 2 Cov.: 33 AF XY: 0.00270 AC XY: 201AN XY: 74418 show subpopulations
GnomAD4 genome
AF:
AC:
433
AN:
152242
Hom.:
Cov.:
33
AF XY:
AC XY:
201
AN XY:
74418
show subpopulations
African (AFR)
AF:
AC:
408
AN:
41518
American (AMR)
AF:
AC:
12
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7
AN:
68028
Other (OTH)
AF:
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
25
49
74
98
123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.